BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 25110240)

  • 1. The expression of STAT3, BCL-XL and MMP-2 proteins in colon adenocarcinomas and their relationship with prognostic factors.
    Artaş G; Ozercan HI
    Turk Patoloji Derg; 2014; 30(3):178-83. PubMed ID: 25110240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Immunohistochemical Expression of STAT3, Bcl-xL, and MMP-2 Proteins in Colon Adenoma and Adenocarcinoma.
    Lee SW; Ahn YY; Kim YS; Kang SB; Nam SW; Lee DS; Jeong HY; Kim JM
    Gut Liver; 2012 Jan; 6(1):45-51. PubMed ID: 22375170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STAT3 mRNA and protein expression in colorectal cancer: effects on STAT3-inducible targets linked to cell survival and proliferation.
    Lassmann S; Schuster I; Walch A; Göbel H; Jütting U; Makowiec F; Hopt U; Werner M
    J Clin Pathol; 2007 Feb; 60(2):173-9. PubMed ID: 17264243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of E-cadherin with STAT3 and apoptosis regulators: Bak and Bcl-xL in endometrioid adenocarcinomas of different ER-alpha immunoprofile.
    Sulkowska U; Wincewicz A; Kanczuga-Koda L; Koda M; Sulkowski S
    Gynecol Endocrinol; 2018 Feb; 34(2):171-174. PubMed ID: 28937296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of STAT5 and Bcl-xL, and high expression of Neu and STAT3 in non-small-cell lung carcinoma.
    Sánchez-Ceja SG; Reyes-Maldonado E; Vázquez-Manríquez ME; López-Luna JJ; Belmont A; Gutiérrez-Castellanos S
    Lung Cancer; 2006 Nov; 54(2):163-8. PubMed ID: 16959370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of Bcl-xL gene expression in human colorectal cancer.
    Jin-Song Y; Zhao-Xia W; Cheng-Yu L; Xiao-Di L; Ming S; Yuan-Yuan G; Wei D
    Acta Histochem; 2011 Dec; 113(8):810-4. PubMed ID: 21277008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inverse association between Raf Kinase Inhibitory Protein and signal transducers and activators of transcription 3 expression in gastric adenocarcinoma patients: implications for clinical outcome.
    Chatterjee D; Sabo E; Tavares R; Resnick MB
    Clin Cancer Res; 2008 May; 14(10):2994-3001. PubMed ID: 18483365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression and clinical significance of IGF-II mRNA and bcl-2 protein in colorectal adenocarcinomas].
    Zhang MS; Yuan HY; Xiong B; Deng Q; Tang ZJ; Xia D
    Ai Zheng; 2002 Nov; 21(11):1226-30. PubMed ID: 12526221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of phosphorylated Stat3, cyclin D1 and Bcl-xL in extramammary Paget disease.
    Liu HJ; Moroi Y; Masuda T; Yasumoto S; Kokuba H; Imafuku S; Koga T; Tetsuya T; Tu YT; Aburatani H; Furue M; Urabe K
    Br J Dermatol; 2006 May; 154(5):926-32. PubMed ID: 16634897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis.
    Rosen DG; Mercado-Uribe I; Yang G; Bast RC; Amin HM; Lai R; Liu J
    Cancer; 2006 Dec; 107(11):2730-40. PubMed ID: 17063503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptotic and mitotic indices predict survival rates in lymph node-negative colon carcinomas.
    Sinicrope FA; Hart J; Hsu HA; Lemoine M; Michelassi F; Stephens LC
    Clin Cancer Res; 1999 Jul; 5(7):1793-804. PubMed ID: 10430084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationship of Stat3 and its target gene products with malignancy in human colorectal carcinoma].
    Ma XT; Wang S; Ye YJ; Du RY; Cui ZR
    Ai Zheng; 2003 Nov; 22(11):1135-9. PubMed ID: 14613639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microenvironment influence on human colon adenocarcinoma phenotypes and matrix metalloproteinase-2, p53 and β-catenin tumor expressions from identical monoclonal cell tumor in the orthotopic model in athymic nude rats.
    Priolli DG; Abrantes AM; Neves S; Gonçalves AC; Lopes CO; Martinez NP; Cardinalli IA; Ribeiro AB; Botelho MF
    Scand J Gastroenterol; 2014 Mar; 49(3):309-16. PubMed ID: 24325610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STAT3 and apoptosis regulators: Bak and Bcl-xL in endometrioid adenocarcinomas of different estrogen receptor-α immunoprofile.
    Wincewicz A; Baltaziak M; Kanczuga-Koda L; Koda M; Sulkowska U; Famulski W; Sulkowski S
    Gynecol Endocrinol; 2011 Aug; 27(8):536-40. PubMed ID: 21726118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of minichromosome maintenance protein 2 in colonic adenocarcinoma, adenoma and normal colonic mucosa and its clinical significance].
    Wang Y; Zhou ZG; Xia QJ; Zhang WY; Li HG; Wang R
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Sep; 11(5):465-8. PubMed ID: 18803052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of matrix metalloproteinase-2, cathepsin D, and tenascin-C expression in colorectal carcinoma.
    Sis B; Sağol O; Küpelioğlu A; Sokmen S; Terzi C; Fuzun M; Ozer E; Bishop P
    Pathol Res Pract; 2004; 200(5):379-87. PubMed ID: 15239346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and clinical significance of CD74 and MMP-9 in colon adenocarcinomas.
    Ruan P; Gu Y; Zhou H; Zhang W; Wang D; Liang J; Li C
    J BUON; 2020; 25(2):927-932. PubMed ID: 32521887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas.
    Krajewska M; Moss SF; Krajewski S; Song K; Holt PR; Reed JC
    Cancer Res; 1996 May; 56(10):2422-7. PubMed ID: 8625322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of epidermal growth factor receptor in normal colonic mucosa and in adenocarcinomas of the colon.
    Ozğul C; Karaöz E; Erdoğan D; Dursun A
    Acta Physiol Hung; 1997-1998; 85(2):121-8. PubMed ID: 9706306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of STAT3 is a marker of poor prognosis in human colorectal cancer.
    Kusaba T; Nakayama T; Yamazumi K; Yakata Y; Yoshizaki A; Inoue K; Nagayasu T; Sekine I
    Oncol Rep; 2006 Jun; 15(6):1445-51. PubMed ID: 16685378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.